Literature DB >> 12692082

Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures.

Ana P Silva1, Paulo S Pinheiro, Arsélio P Carvalho, Caetana M Carvalho, Birthe Jakobsen, Jens Zimmer, João O Malva.   

Abstract

Glutamate and NPY have been implicated in hippocampal neuropathology in temporal lobe epilepsy. Thus, we investigated the involvement of NPY receptors in mediating neuroprotection against excitotoxic insults in organotypic cultures of rat hippocampal slices. Exposure of hippocampal slice cultures to 2 microM AMPA (alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate) induced neuronal degeneration, monitored by propidium iodide uptake, of granule cells and CA1 pyramidal cells. For dentate granule cells, selective activation of Y1, Y2, or Y5 receptors with 1 microM [Leu31,Pro34]NPY, 300 nM NPY13-36 or 1 microM 500 nM NPY(19-23)-(Gly1,Ser3,Gln4,Thr6,Ala31,Aib32,Gln34)-PP, respectively, had a neuroprotective effect against AMPA, whereas only the activation of Y2 receptors was effective for CA1 pyramidal cells. When the slice cultures were exposed to 6 microM kainate, the CA3 pyramidal cells displayed significant degeneration, and in this case the activation of Y1, Y2, and Y5 receptors was neuroprotective. For the kainic acid-induced degeneration of CA1 pyramidal cells, it was again found that only the Y2 receptor activation was effective. Based on the present findings, it was concluded that Y1, Y2, and Y5 receptors effectively can modify glutamate receptor-mediated neurodegeneration in the hippocampus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692082     DOI: 10.1096/fj.02-0885fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  21 in total

Review 1.  Presynaptic modulation controlling neuronal excitability and epileptogenesis: role of kainate, adenosine and neuropeptide Y receptors.

Authors:  João O Malva; Ana P Silva; Rodrigo A Cunha
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

2.  Gene therapy in epilepsy.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

Review 3.  Neuropeptide Y Y2 receptor in health and disease.

Authors:  S L Parker; A Balasubramaniam
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

4.  Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum.

Authors:  Nathalie Thiriet; Xiaolin Deng; Marcello Solinas; Bruce Ladenheim; Wendy Curtis; Steven R Goldberg; Richard D Palmiter; Jean Lud Cadet
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

5.  Spatial and temporal immunoreactivity in the rat brain using an affinity purified polyclonal antibody to DNSP-11.

Authors:  James W H Sonne; Jason S Groshong; Corey Seavey; Don M Gash
Journal:  J Chem Neuroanat       Date:  2019-08-05       Impact factor: 3.052

6.  Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease.

Authors:  John B Rose; Leslie Crews; Edward Rockenstein; Anthony Adame; Michael Mante; Louis B Hersh; Fred H Gage; Brian Spencer; Rewati Potkar; Robert A Marr; Eliezer Masliah
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

Review 7.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

8.  Neuroprotective properties of Valeriana officinalis extracts.

Authors:  João O Malva; Sandra Santos; Tice Macedo
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

9.  Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.

Authors:  Haley L Yarosh; Jesus A Angulo
Journal:  Brain Res       Date:  2012-09-13       Impact factor: 3.252

10.  Neuropeptide Y protects rat cortical neurons against β-amyloid toxicity and re-establishes synthesis and release of nerve growth factor.

Authors:  Nicoletta Croce; Maria Teresa Ciotti; Francesca Gelfo; Silvia Cortelli; Giorgio Federici; Carlo Caltagirone; Sergio Bernardini; Francesco Angelucci
Journal:  ACS Chem Neurosci       Date:  2012-01-30       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.